Mary K Dahmer Selected Research

Mary K Dahmer Research Topics

Disease

15	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 05/2004
11	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 05/2004
7	Acute Lung Injury 01/2022 - 11/2008
7	Lung Injury 01/2020 - 11/2008
7	Pneumonia (Pneumonitis) 01/2016 - 05/2004
5	Lung Diseases (Lung Disease) 07/2021 - 01/2010
3	Inflammation (Inflammations) 06/2022 - 01/2017
3	Sepsis (Septicemia) 01/2022 - 01/2014
3	Critical Illness (Critically Ill) 01/2022 - 01/2016
3	Septic Shock (Toxic Shock Syndrome) 01/2016 - 05/2004
2	Asthma (Bronchial Asthma) 01/2019 - 01/2006
2	Hypertension (High Blood Pressure) 03/2012 - 09/2010
1	Delirium 07/2022
1	Pleural Effusion (Pleural Effusions) 06/2022
1	Necrosis 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Thrombosis (Thrombus) 01/2021
1	Vascular System Injuries 01/2021
1	Obesity 10/2020
1	Sudden Infant Death (SID) 09/2020
1	Respiratory Distress Syndrome In Premature Infants 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2016
1	Edema (Dropsy) 06/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2012
1	Pulmonary Hypertension 10/2011
1	Status Asthmaticus 01/2006
1	Neuroblastoma 05/2005

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2015
3	Interleukin-8 (Interleukin 8)IBA 01/2022 - 01/2019
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2021 - 11/2008
3	Proteins (Proteins, Gene)FDA Link 10/2018 - 01/2010
2	CytokinesIBA 06/2022 - 01/2019
2	ThrombomodulinIBA 07/2021 - 01/2021
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 10/2020 - 01/2020
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2019 - 01/2017
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2016 - 11/2012
2	IgA receptor (protein B)IBA 05/2011 - 05/2004
2	Surface-Active Agents (Surfactants)IBA 05/2011 - 05/2004
2	Amino Acids FDA Link 01/2010 - 01/2006
1	InterleukinsIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	DiureticsIBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2021
1	PlasminogenIBA 01/2021
1	Protein CIBA 01/2021
1	Thrombin FDA Link 01/2021
1	AntigensIBA 09/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	LipopolysaccharidesIBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	EndotoxinsIBA 01/2017
1	RNA Splicing FactorsIBA 01/2016
1	Epidermal Growth Factor (EGF)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Proprotein Convertase 9IBA 01/2016
1	von Willebrand FactorIBA 01/2016
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2016
1	Toll-Like Receptor 1IBA 01/2016
1	ElafinIBA 01/2016
1	Caspase 12IBA 01/2014
1	Interleukin-1 (Interleukin 1)IBA 04/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2012
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2011
1	Myosin-Light-Chain KinaseIBA 11/2010
1	beta Adrenergic ReceptorsIBA 09/2010
1	Arginine (L-Arginine)FDA Link 01/2010
1	Adenosine Triphosphate (ATP)IBA 01/2010
1	Cysteine (L-Cysteine)FDA Link 01/2010
1	NucleotidesIBA 11/2008
1	Bronchodilator Agents (Bronchodilators)IBA 01/2006
1	Aminophylline (Carine)FDA LinkGeneric 01/2006
1	ThapsigarginIBA 05/2005
1	Caspase 2IBA 05/2005

Therapy/Procedure

7	Artificial Respiration (Mechanical Ventilation) 01/2022 - 05/2004
5	Therapeutics 01/2022 - 01/2006
4	Length of Stay 07/2022 - 01/2016
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 11/2008
2	Mechanical Ventilators (Ventilator) 01/2022 - 01/2020
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 07/2022
1	Chest Tubes (Chest Tube) 06/2022
1	Fontan Procedure (Fontan Operation) 06/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Hematopoietic Stem Cell Transplantation 04/2012